Merus (MRUS)
(Delayed Data from NSDQ)
$67.45 USD
+0.52 (0.78%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $67.47 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2025
Time: -- |
9/2025 | $-1.15 | 0.00% |
Earnings Summary
For their last quarter, Merus (MRUS) reported earnings of -$2.23 per share, missing the Zacks Consensus Estimate of -$1.17 per share. This reflects a negative earnings surprise of 90.60%. Look out for MRUS's next earnings release expected on August 05, 2025. For the next earning release, we expect the company to report earnings of -$1.15 per share, reflecting a year-over-year decrease of 44.44%.
Earnings History
Price & Consensus
Zacks News for MRUS
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
MRUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
MRUS FAQs
Based on past history, Zacks believes Merus N.V. (MRUS) will report their next quarter earnings on August 07, 2025. For the next earning release, we expect the company to report earnings of -1.17 per share, reflecting a year-over-year increase of -44.44.
Based on past history, Zacks believes Merus N.V. (MRUS) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on August 07, 2025.
The Zacks Consensus Estimate for Merus N.V. (MRUS) for the quarter ending June 2025 is $-1.17 a share. We expect Merus N.V. (MRUS) to report earnings in line with the consensus estimate of $-1.17 per share
In the earnings report for the quarter ending in September 2024, Merus N.V. (MRUS) announced earnings of $-0.95 per share versus the Zacks Consensus Estimate of $-0.90 per share, representing a surprise of 5.56%.